Discover
TXG
10x Genomics, Inc.
39.05
2 x 28.58
2 x 48.46
bid
ask
+
0.71
1.85%
2 @ 04:00 PM
39.36 +0.31 (0.79%)
| Ytd | 139.42% | |
| 1y | 200.15% |
37.65
day range
40.08
11.16
52 week range
40.08
| Open | 38.40 | Prev Close | 38.34 | Low | 37.65 | High | 40.08 | Mkt Cap | 4.96B |
| Vol | 3.18M | Avg Vol | 3.04M | EPS | -0.17 | P/E | N/A | Forward P/E | 195.25 |
| Beta | 2.11 | Short Ratio | 6.94 | Inst. Own | 111.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 27.14 | 200-d Avg | 20.00 | 1yr Est | 27.62 |
| Income Statement | |||
| Total Revenue | 150.84M | ||
| Revenues (USD) | 150.84M | ||
| Cost of Revenue | 44.67M | ||
| Gross Profit | 106.18M | ||
| Operating Expenses | 123.22M | ||
| Research and Development Expense | 56.85M | ||
| Selling, General and Administrative Expense | 66.38M | ||
| Operating Income | -17.05M | ||
| Income Tax Expense | 623.00K | ||
| Net Income | -13.47M | ||
| Net Income Common Stock | -13.47M | ||
| Net Income Common Stock (USD) | -13.47M | ||
| Consolidated Income | -13.47M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -12.85M | ||
| Earning Before Interest & Taxes (USD) | -12.85M | ||
| Weighted Average Shares | 128.29M | ||
| Weighted Average Shares Diluted | 128.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 490.29M | ||
| Cash and Equivalents (USD) | 490.29M | ||
| Investments | 49.56M | ||
| Investments Current | 49.56M | ||
| Trade and Non-Trade Receivables | 56.14M | ||
| Current Assets | 669.73M | ||
| Property, Plant & Equipment Net | 278.98M | ||
| Total Assets | 1.02B | ||
| Debt Current | 11.33M | ||
| Total Debt | 81.39M | ||
| Current Liabilities | 113.60M | ||
| Debt Non-Current | 70.06M | ||
| Total Liabilities | 201.44M | ||
| Accumulated Retained Earnings (Deficit) | -1.52B | ||
| Accumulated Other Comprehensive Income | 114.00K | ||
| Shareholders Equity | 814.32M | ||
| Shareholders Equity (USD) | 814.32M | ||
| Assets Non-Current | 346.03M | ||
| Total Debt (USD) | 81.39M | ||
| Deferred Revenue | 34.48M | ||
| Goodwill and Intangible Assets | 64.42M | ||
| Inventory | 53.49M | ||
| Liabilities Non-Current | 87.84M | ||
| Trade and Non-Trade Payables | 17.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.91M | ||
| Net Cash Flow from Financing | -8.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 16.32M | ||
| Capital Expenditure | -1.60M | ||
| Issuance (Purchase) of Equity Shares | 273.00K | ||
| Net Cash Flow from Investing | -1.31M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 286.00K | ||
| Net Cash Flow from Operations | 26.12M | ||
| Effect of Exchange Rate Changes on Cash | -73.00K | ||
| Share Based Compensation | 22.64M | ||